Peer reviewer reports are available
These medications reduce gastric acid production, which is necessary for releasing dietary vitamin B12 from food proteins and for maintaining the stability of the B12-intrinsic factor complex
IGF-1 treatment: future and limitations The FDA approved the use of rhIGF-1 (Mecasermin, Increlex) for treatment of severe primary IGF-1 deficiency in 2003
IV Therapy Add-Ons At Mobile IV Medics, we offer a wide selection of specially crafted IV treatment packages to address common symptoms of dehydration, overexertion, hangovers and other illnesses
Adding barrier contraception during the dose-titration phase is advised, or switching to a vaginal ring or transdermal patch (160, 162)
1: Mtodos qumicos e fsicos para anlise de alimentos, 3rd edn